2023-08-01 13:28:57 ET
- United Therapeutics ( NASDAQ: UTHR ) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, before market open.
- The consensus EPS Estimate is $4.78 (vs. $2.41 last year) and the consensus Revenue Estimate is $524.17M (+12.3% Y/Y).
- Over the last 1 year, UTHR has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 2 upward revisions and 8 downward.
For further details see:
United Therapeutics Q2 2023 Earnings Preview